50% OFF
MarketBeat All Access
Get 30 days free. Save 50% your first year.
  •  days
  •  Hours
  •  Minutes
  •  Seconds
×
S&P 500   3,719.04 (+1.97%)
DOW   29,683.74 (+1.88%)
QQQ   279.94 (+1.99%)
AAPL   149.84 (-1.27%)
MSFT   241.07 (+1.97%)
META   141.61 (+5.36%)
GOOGL   100.05 (+2.62%)
AMZN   118.01 (+3.15%)
TSLA   287.81 (+1.72%)
NVDA   127.36 (+2.60%)
NIO   17.33 (+0.81%)
BABA   80.99 (+4.01%)
AMD   68.36 (+1.77%)
T   15.83 (+0.64%)
MU   51.00 (+0.83%)
CGC   3.04 (+6.29%)
F   12.18 (+2.27%)
GE   64.46 (-0.02%)
DIS   99.40 (+3.70%)
AMC   7.67 (+2.95%)
PYPL   91.12 (+6.26%)
PFE   44.43 (+0.77%)
NFLX   245.20 (+9.29%)
S&P 500   3,719.04 (+1.97%)
DOW   29,683.74 (+1.88%)
QQQ   279.94 (+1.99%)
AAPL   149.84 (-1.27%)
MSFT   241.07 (+1.97%)
META   141.61 (+5.36%)
GOOGL   100.05 (+2.62%)
AMZN   118.01 (+3.15%)
TSLA   287.81 (+1.72%)
NVDA   127.36 (+2.60%)
NIO   17.33 (+0.81%)
BABA   80.99 (+4.01%)
AMD   68.36 (+1.77%)
T   15.83 (+0.64%)
MU   51.00 (+0.83%)
CGC   3.04 (+6.29%)
F   12.18 (+2.27%)
GE   64.46 (-0.02%)
DIS   99.40 (+3.70%)
AMC   7.67 (+2.95%)
PYPL   91.12 (+6.26%)
PFE   44.43 (+0.77%)
NFLX   245.20 (+9.29%)
S&P 500   3,719.04 (+1.97%)
DOW   29,683.74 (+1.88%)
QQQ   279.94 (+1.99%)
AAPL   149.84 (-1.27%)
MSFT   241.07 (+1.97%)
META   141.61 (+5.36%)
GOOGL   100.05 (+2.62%)
AMZN   118.01 (+3.15%)
TSLA   287.81 (+1.72%)
NVDA   127.36 (+2.60%)
NIO   17.33 (+0.81%)
BABA   80.99 (+4.01%)
AMD   68.36 (+1.77%)
T   15.83 (+0.64%)
MU   51.00 (+0.83%)
CGC   3.04 (+6.29%)
F   12.18 (+2.27%)
GE   64.46 (-0.02%)
DIS   99.40 (+3.70%)
AMC   7.67 (+2.95%)
PYPL   91.12 (+6.26%)
PFE   44.43 (+0.77%)
NFLX   245.20 (+9.29%)
S&P 500   3,719.04 (+1.97%)
DOW   29,683.74 (+1.88%)
QQQ   279.94 (+1.99%)
AAPL   149.84 (-1.27%)
MSFT   241.07 (+1.97%)
META   141.61 (+5.36%)
GOOGL   100.05 (+2.62%)
AMZN   118.01 (+3.15%)
TSLA   287.81 (+1.72%)
NVDA   127.36 (+2.60%)
NIO   17.33 (+0.81%)
BABA   80.99 (+4.01%)
AMD   68.36 (+1.77%)
T   15.83 (+0.64%)
MU   51.00 (+0.83%)
CGC   3.04 (+6.29%)
F   12.18 (+2.27%)
GE   64.46 (-0.02%)
DIS   99.40 (+3.70%)
AMC   7.67 (+2.95%)
PYPL   91.12 (+6.26%)
PFE   44.43 (+0.77%)
NFLX   245.20 (+9.29%)
NASDAQ:NMTC

NeuroOne Medical Technologies - NMTC Stock Forecast, Price & News

$1.72
-0.03 (-1.71%)
(As of 09/28/2022 12:00 AM ET)
Add
Compare
Today's Range
$1.70
$1.79
50-Day Range
$1.03
$2.55
52-Week Range
$0.51
$4.25
Volume
9,262 shs
Average Volume
140,808 shs
Market Capitalization
$27.88 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$2.63

NeuroOne Medical Technologies MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.50 Rating Score
Upside/​Downside
52.6% Upside
$2.63 Price Target
Short Interest
Healthy
0.36% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.69mentions of NeuroOne Medical Technologies in the last 14 days
Based on 3 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.88 out of 5 stars

Medical Sector

823rd out of 1,096 stocks

Surgical & Medical Instruments Industry

83rd out of 108 stocks

NMTC stock logo

About NeuroOne Medical Technologies (NASDAQ:NMTC) Stock

NeuroOne Medical Technologies Corporation operates as a medical technology company. The company focuses on the development and commercialization of thin film electrode technology for continuous electroencephalogram (cEEG) and stereoelectroencephalography (sEEG) recording, spinal cord stimulation, brain stimulation, and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, chronic pain due to failed back surgeries, and other related neurological disorders. It has a strategic partnership with RBC Medical Innovations to develop a radio frequency ablation generator for use with NeuroOne's combination recording and ablation electrode to record brain activity and ablate brain tissue using the same electrode. The company is based in Eden Prairie, Minnesota.

Receive NMTC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for NeuroOne Medical Technologies and its competitors with MarketBeat's FREE daily newsletter.

NMTC Stock News Headlines

NeuroOne Medical Technologies (NASDAQ:NMTC) Trading Down 8.4%
Why NeuroOne Medical Technologies Shares Are Rising
NeuroOne Provides Evo® sEEG Update
NeuroOne Medical FQ2 Net Loss of $3.1M
See More Headlines
Receive NMTC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for NeuroOne Medical Technologies and its competitors with MarketBeat's FREE daily newsletter.

NMTC Company Calendar

Last Earnings
8/11/2022
Today
9/28/2022
Fiscal Year End
9/30/2022
Next Earnings (Estimated)
12/21/2022

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:NMTC
Fax
N/A
Employees
2,019
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$2.63
High Stock Price Forecast
$3.25
Low Stock Price Forecast
$2.00
Forecasted Upside/Downside
+52.6%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.50
Research Coverage
2 Analysts

Profitability

Net Income
$-9,950,000.00
Net Margins
-7,177.71%
Pretax Margin
-7,177.07%

Debt

Sales & Book Value

Annual Sales
$180,000.00
Book Value
$0.55 per share

Miscellaneous

Free Float
14,977,000
Market Cap
$27.88 million
Optionable
Not Optionable
Beta
-0.48

Key Executives

  • Mr. David A. Rosa M.D. (Age 58)
    Pres, CEO & Director
    Comp: $603.45k
  • Mr. Ronald W. McClurg (Age 63)
    Chief Financial Officer
    Comp: $294.47k
  • Mr. Steven Mertens (Age 59)
    Chief Technology Officer
    Comp: $298.97k
  • Mr. Mark ChristiansonMr. Mark Christianson (Age 55)
    Co-Founder, Bus. Devel. Director & Medical Sales Liaison
  • Mr. Hijaz Haris
    VP of Marketing













NMTC Stock - Frequently Asked Questions

Should I buy or sell NeuroOne Medical Technologies stock right now?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for NeuroOne Medical Technologies in the last year. There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" NMTC shares.
View NMTC analyst ratings
or view top-rated stocks.

What is NeuroOne Medical Technologies' stock price forecast for 2022?

2 Wall Street research analysts have issued 1-year target prices for NeuroOne Medical Technologies' stock. Their NMTC share price forecasts range from $2.00 to $3.25. On average, they anticipate the company's share price to reach $2.63 in the next twelve months. This suggests a possible upside of 50.0% from the stock's current price.
View analysts price targets for NMTC
or view top-rated stocks among Wall Street analysts.

How have NMTC shares performed in 2022?

NeuroOne Medical Technologies' stock was trading at $1.94 at the beginning of the year. Since then, NMTC stock has decreased by 9.8% and is now trading at $1.75.
View the best growth stocks for 2022 here
.

When is NeuroOne Medical Technologies' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, December 21st 2022.
View our NMTC earnings forecast
.

How were NeuroOne Medical Technologies' earnings last quarter?

NeuroOne Medical Technologies Co. (NASDAQ:NMTC) announced its earnings results on Thursday, August, 11th. The company reported ($0.17) earnings per share for the quarter. The firm had revenue of $0.03 million for the quarter. NeuroOne Medical Technologies had a negative trailing twelve-month return on equity of 97.47% and a negative net margin of 7,177.71%.

What is NeuroOne Medical Technologies' stock symbol?

NeuroOne Medical Technologies trades on the NASDAQ under the ticker symbol "NMTC."

Who are NeuroOne Medical Technologies' major shareholders?

NeuroOne Medical Technologies' stock is owned by many different institutional and retail investors. Top institutional investors include Kingsbury Capital Investment Advisors LLC (0.33%) and Concourse Financial Group Securities Inc. (0.00%). Insiders that own company stock include Mark Christianson and Ronald W Mcclurg.
View institutional ownership trends
.

How do I buy shares of NeuroOne Medical Technologies?

Shares of NMTC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is NeuroOne Medical Technologies' stock price today?

One share of NMTC stock can currently be purchased for approximately $1.75.

How much money does NeuroOne Medical Technologies make?

NeuroOne Medical Technologies (NASDAQ:NMTC) has a market capitalization of $28.37 million and generates $180,000.00 in revenue each year. The company earns $-9,950,000.00 in net income (profit) each year or ($0.76) on an earnings per share basis.

How many employees does NeuroOne Medical Technologies have?

The company employs 2,019 workers across the globe.

How can I contact NeuroOne Medical Technologies?

NeuroOne Medical Technologies' mailing address is 10006 Liatris Ln, EDEN PRAIRIE, MN 55347-1210, United States. The official website for the company is www.originalsourcemusic.com. The company can be reached via phone at (952) 426-1383 or via email at james@haydenir.com.

This page (NASDAQ:NMTC) was last updated on 9/28/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.